Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring longterm intravenous therapy

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2007, Pages

  Hamilton, Helen C ^a   Foxcroft, David ^b  

^a Rigshospitalet   (Denmark)

^b OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Bacterial infections *prevention control ; Catheterization, central venous adverse effects; *methods ; Constriction, pathologic prevention control ; Femoral vein; Jugular veins; Subclavian vein

Indexed keywords

ARTERY PUNCTURE; BLEEDING; CATHETER INFECTION; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; FEMORAL VEIN; HEMATOMA; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTIOUS COMPLICATION; INTRAVENOUS CATHETER; JUGULAR VEIN; LONG TERM CARE; REVIEW; SEPSIS; STENOSIS; SUBCLAVIAN VEIN; SYSTEMATIC REVIEW; VASCULAR ACCESS; VEIN THROMBOSIS;

EID: 39749181859     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004084.pub2     Document Type: Review

References (19)

1. Merrer 2001 {published data only} * Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy B, Barre E, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001;286(6):700-7. [MEDLINE: 11495620]
2. Darouiche 1999 {published data only} * Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, et al. A comparison of two antimicrobial-impregnated central venous catheters. New England Journal of Medicine 1999;340(1):1-8. [MEDLINE: 9878638]
3. Pemberton 1996 {published data only} * Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters: a prospective randomized trial. Archives of Surgery 1996;131:986-9. [MEDLINE: 8790170]
4. Raad 1997 {published data only} * Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with Minocycline and Rifampin for the prevention of catheter-related colonization and bloodstream infections. Annals of Internal Medicine 1997;127:267-74. [MEDLINE: 9265425]
5. Safdar 2002 {published data only} * Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Critical Care Medicine 2002;30(12):2632-5. [MEDLINE: 12483050]
6. Timsit 1996 {published data only} * Timsit JF, Sebille V, Farkas JC, Misset B, Martin JB, Chevret S, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996;276(17):1416-20. [MEDLINE: 8892717]
7. Alhimyary 1996 Alhimyary A, Fernandez C, Picard M, Tierno K, Pignatone N, Chan HS, et al. Safety and efficacy of total parenteral nutrition delivered via a peripherally inserted central venous catheter. Nutrition and Clinical Practice 1996;11(5):199-203. [MEDLINE: 9016135]
8. Bern 1990 Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Annals of Internal Medicine 1990;112(6):423-8. [MEDLINE: 2178534]
9. Deshpande 2005 Deshpande KS, Hatem C, Ulrich HL, Currie BP, Aldrich TK, Bryan-Brown CW, et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Critical Care Medicine 2005;33(1):13-20.
10. Goetz 1998 Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infection Control and Hospital Epidemiology 1998;19(11):842-5.
11. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]; Section 11a.15 Appendix B. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd..
12. Hye 1996 Hye RJ, Stabile BE. Complications of percutaneous vascular access procedures and their management. In: Wilson SE editor(s). Vascular access: principles and practice. 3rd Edition. St Louis: Mosby, 1996: 92-103.
13. Ioannidis 2005 Ioannidis JPA. Why most published research findings are false. PLoS Medicine 2005;2(8(e124)):696-701.
14. Lorente 2005 Lorente L, Henry C, Martin MA, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Critical Care 2005;9(6):R631-5.
15. Raad 2002 Raad II, Hanna HA. Intravascular catheter-related infections: new horizons and recent advances. Archives of Internal Medicine 2002;162(8):871-8.
16. Reusch 2002 Reusch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access - a systematic review. Critical Care Medicine 2002;30(2):454-60.
17. RevMan 4.2 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
18. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408- 12. [MEDLINE: 7823387]
19. Yellin 1996 Yellin AE, Hood DB, Weaver FA. Axillo-subclavian vein thrombosis. In: Wilson SE editor(s). Vascular access: principles and practice. 3rd Edition. St Louis: Mosby, 1996:104-9.